Results 221 to 230 of about 175,800 (301)

Testicular Embryonal Carcinoma With Retroperitoneal Metastasis and Normal AFP and HCG: A Case Report. [PDF]

Case Rep Oncol Med
Teng P, Yang M, Song S.
europepmc   +1 more source

Radioembolization (90Y) achieves higher response rates and reduces progression risk compared with DEB-TACE in hepatocellular carcinoma. [PDF]

Hepatol Commun
Núñez K, Núñez K, Hasani N, Cronan J, Gimenez J, Cohen A, Sandow T, Thevenot P.   +7 more
europepmc   +1 more source

Intratumoral Proton Density Fat Fraction Predicts the Outcome of HAIC Combined With PD‐1 Inhibitors in Advanced Hepatocellular Carcinoma

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Background and Aims This study aimed to explore the predictive value of intratumoral proton density fat fraction (PDFF) and the clinical efficacy of hepatic arterial infusion chemotherapy (HAIC) combined with anti‐programmed cell death protein 1 (anti‐PD‐1) therapy in advanced hepatocellular carcinoma (HCC).
Yujie Ye, Yunzheng Li, Yanjun Lu, Yanchao Xu, Laizhu Zhang, Yican Zhu, Huan Li, Binghua Li, Min Zhou, Decai Yu   +9 more
wiley   +1 more source

Intratumoral PD-1^high CD8⁺ T cells correlate with AFP levels in HCC patients: a brief report. [PDF]

Cell Oncol (Dordr)
Macek Jilkova Z, Ghelfi J, Dumolard L, Sengel C, Brusset B, Teyssier Y, Costentin C, Decaens T.   +7 more
europepmc   +1 more source

The Differences in Clinical Outcomes for Unresectable Huge (≥ 10 cm) Hepatocellular Carcinoma With Portal Vein Thrombosis Treated by Two Different Radiotherapy Techniques

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Aims To explore a safe and effective treatment modality for unresectable huge (≥ 10 cm) hepatocellular carcinoma with portal vein thrombosis. And to provide more data on the synergistic antitumor effects of radiotherapy combined with immune checkpoint inhibitors and antiangiogenic therapy. Materials and Methods This study compared the clinical
ZengLiang Huang, ZhongHua Chen, JuanJuan Shen, JianHai Lin, ShiLong Den, NanBao Zhong   +5 more
wiley   +1 more source

Sub-national modelling of surveillance sensitivity to inform declaration of disease elimination: A retrospective validation against the elimination of wild poliovirus in Nigeria. [PDF]

PLoS Comput Biol
Nightingale ES, Pham-Minh L, Bello IM, Okrior S, Erbeto TB, Baba M, Adeneji A, Auzenbergs M, Edmunds WJ, O'Reilly KM.   +9 more
europepmc   +1 more source

Visualized Clinical‐Radiomics Model Based on Non‐Contrast Computed Tomography for Predicting Efficacy of Surufatinib in Hepatic Metastases of Neuroendocrine Neoplasms

Cancer Medicine, Volume 15, Issue 5, May 2026.
NCCT radiomics for surufatinib efficacy prediction in HM‐NENs. ABSTRACT Background Hepatic metastatic neuroendocrine neoplasms (HM‐NENs) have few treatment biomarkers and low survival rates. We created a clinical‐radiomics fusion model based on non‐contrast computed tomography (NCCT) to predict Surufatinib efficacy in HM‐NENs.
Miaomiao Feng, Man Zhao, Xiaoling Duan, Jiaojiao Hou, Qi Wang, Fei Yin   +5 more
wiley   +1 more source

Primary vaginal yolk sac tumor in an 11-month-old girl: a case report. [PDF]

Front Oncol
You J, Xia W.
europepmc   +1 more source

A Real‐World Experience of Prognostic Factors of Survival Outcomes in a Taiwanese Population With Unresectable Hepatocellular Carcinoma Treated With First‐Line Lenvatinib

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Introduction Lenvatinib is approved as a first‐line treatment for unresectable hepatocellular carcinoma (HCC), but real‐world outcomes may vary due to patient heterogeneity. This study aimed to evaluate the real‐world efficacy of lenvatinib in Taiwanese patients and to identify prognostic factors influencing outcomes.
Shou‐Wu Lee, Yi‐Jie Huang, Hsin‐Ju Tsai, Ying‐Cheng Lin, Chia‐Chang Chen, Teng‐Yu Lee, Yen Chun‐Peng   +6 more
wiley   +1 more source

Hepatocellular Carcinoma Arising from Ectopic Liver Tissue in the Left Triangular Ligament: A Case Report. [PDF]

J Korean Soc Radiol
Shin YK, Gil JR, Yoon HJ, Kim YJ.
europepmc   +1 more source